BiotechTube
Epitype

Epitype

Berlin, Germany· Est.
epitype.de
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.8M

Overview

Epitype GmbH is a molecular diagnostics company based in Jena, Germany, originally founded as oncgnostics GmbH in 2012 and rebranded in 2025. The company has developed and commercialized GynTect®, a DNA methylation-based test for cervical cancer, and is expanding its biomarker platform to other cancer types. Despite its innovative technology and product, the company's predecessor (oncgnostics GmbH) filed for insolvency in March 2025, indicating significant financial and operational challenges that the newly named entity must overcome.

OncologyWomen's Health

Technology Platform

Proprietary DNA methylation biomarker discovery and validation platform for cancer diagnostics.

Funding History

1
Total raised:$1.8M
Seed$1.8M

Opportunities

The WHO's global push to eliminate cervical cancer creates a major tailwind for improved triage diagnostics like GynTect®.
The company's patented methylation biomarker platform is clinically validated and could be expanded to other high-value cancer diagnostic areas, such as colorectal or lung cancer, through partnerships.

Risk Factors

The company's predecessor filed for insolvency in March 2025, indicating severe financial distress and casting extreme doubt on the current entity's viability.
Commercial success depends on displacing or complementing entrenched screening methods in a competitive market, requiring significant commercial execution capabilities the company has historically lacked.

Competitive Landscape

Epitype competes in the cervical cancer diagnostics space against large IVD companies like Roche, Hologic, and Qiagen that offer primary HPV tests, as well as other molecular triage assays. Its differentiation is based on its specific methylation biomarkers, but it faces challenges in market penetration and reimbursement against established players with broader portfolios and sales forces.

More companies in Diagnostics & Precision Medicine →More companies in Germany →